AACC uses cookies to ensure the best website experience. Continuing without changing cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy


Features


In January, the American Red Cross announced it was facing its worst blood shortage in over a decade. The organization cited “relentless challenges” due to the COVID-19 pandemic, including a 10% overall decline in the number of people donating blood, as well as ongoing blood drive cancellations and staffing limitations.…
Rapid antigen tests for SARS-CoV-2 are cheap, fast, and easy to distribute. They are not as accurate as molecular PCR tests. However, their popularity—and availability—continues to grow, especially during variant surges.

Ask the Expert


Bench Matters


Overseeing a mass spectrometry lab is a complex task, whether you're inheriting an already established lab or starting from the ground up. Through my journey of managing a mass spec lab, I learned invaluable lessons in change management—including strategies for implementing new instruments, leading staff, and of course, patience.

Federal Insider


Joined by 19 other healthcare organizations, an AACC coalition is asking Congress to appropriate an additional $7.2 million dollars to the Centers for Disease Control and Prevention (CDC) toward improving clinical laboratory test harmonization.

Industry Playbook


Regulatory Roundup


Illumina recently received the CE mark for TruSight Oncology (TSO) Comprehensive (EU), a single test that assesses multiple tumor genes and biomarkers to reveal the specific molecular profile of a patient’s cancer. According to the company, this test is the first CE-marked IVD kit for comprehensive genetic profiling of cancer…

The Sample